UK Medicines Information
Ilaris (canakinumab): risk minimisation material
Information type:
Safety alerts
Source:
electronic Medicines compendium
Specialities:
Musculo-skeletal disorders
Summary
A healthcare professional’s guide has been produced, covering the indications for use, and alerting to the risks associated with treatment, mainly covering opportunistic infections
UKMi comment
Patient information leaflets have been produced in conjunction.
Related links:
Patient information leaflet: canakinumab for period fever syndromes:
Patient information leaflet: canakinumab for Still’s disease and systemic juvenile idiopathic arthritis
Patient information leaflet: canakinumab for gouty arthritis